Squamous Cell Carcinoma of Nasopharynx

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-10-02
Clinical Trial Update: Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating bevacizumab and erlotinib in recurrent or metastatic head and neck squamous cell carcinoma has completed…